Clinical Updates | Dr. Richard H. Mann

On Treating Alcoholic Peripheral Neuropathy
By Dr. Mann
Blog, Clinical Update
June 24, 2019
Summary: Clinicians should consider the diagnosis of alcoholic polyneuropathy in patients who presently use alcohol excessively and patients who, while currently sober, have a history of such [CLICK TO READ MORE]
Type 2 Diabetes, Foot Ulcers and Cognition
By Dr. Mann
Blog, Clinical Update
May 21, 2019
Summary: Research group finds that type 2 diabetics with foot ulcers possess fewer cognitive resources than a matched group of type 2 diabetics without foot ulcers. The harmful impact of diabetes on [CLICK TO READ MORE]
Benfotiamine and Alzheimer’s Disease
By Dr. Mann
Blog, Clinical Update
April 17, 2019
If you are one of the thousands of physicians who use benfotiamine, a high potency lipid-soluble form of thiamine (vitamin B1), in the treatment of polyneuropathy, you are certainly aware of its [CLICK TO READ MORE]
Peripheral Neuropathy vs. Polyneuropathy
By Dr. Mann
Blog, Clinical Update
April 4, 2019
by Dr. Richard Mann, DABPS, ret, Chief Scientific Officer and Founder, Realm Labs®, sole US distributor of the NeuRemedy® line of benfotiamine products for the healthy function of the nerves in the [CLICK TO READ MORE]
Reversing Thiamine Deficiency in Diabetic Polyneuropathy, an Important Therapeutic Goal
By Dr. Mann
Blog, Clinical Update
March 6, 2019
Clinician Alert: Reversing Thiamine (Vitamin B1) Deficiency in the Treatment of Diabetic Polyneuropathy: An Important Therapeutic Goal by Dr. Richard Mann, DABPS, ret, Chief Scientific Officer & [CLICK TO READ MORE]
Benfotiamine Shown to Improve Symptoms of Peripheral Neuropathy and Cognitive Function in Alcoholics
By Dr. Mann
Blog, Clinical Update
January 28, 2019
Clinician Alert: Patients Successfully Treated with Benfotiamine for Alcoholic Polyneuropathy May Also Experience Improved Cognitive Function by Dr. Richard Mann, DABPS, ret, Chief Scientific Officer [CLICK TO READ MORE]
Is Prediabetes a Risk Factor for Neuropathy?
By Dr. Mann
Blog, Clinical Update
January 7, 2019
Is Prediabetes a Risk Factor for Neuropathy? by Dr. Richard Mann, DABPS, ret, Chief Scientific Officer & Founder, Realm Labs® According to the American Diabetes Association, before people [CLICK TO READ MORE]
Diabetic Polyneuropathy And Metformin
By Dr. Mann
Blog, Clinical Update
December 6, 2018
Metformin Shown to Inhibit Thiamine (Vitamin B1) Absorption, a Contributing Factor in Diabetic Polyneuropathy by Dr. Richard Mann, DABPS, ret, Chief Scientific Officer & Founder, Realm Labs® In [CLICK TO READ MORE]

NeuRemedy^®

Dr. Mann developed the formulation used in NeuRemedy^®, a safe and effective treatment to help relieve numbness, burning, tingling, and shooting pains in the feet and legs. NeuRemedy^®is currently dispensed by internationally by physicians to their patients suffering from these symptoms.

NeuRemedy^®is a nutritional formulation dispensed by physicians to their patients suffering from numbness, tingling, burning and/or shooting pains to the feet and legs.* Such symptoms are commonly associated with diabetes, advanced age, excess alcohol consumption, chemotherapy and/or nerve injury. The physician-formulated NeuRemedy^®line of products is sold exclusively to patients through physicians' offices.

NeuRemedy^®is licensed by Health Canada as an important factor in supporting healthy nerve function in individuals with polyneuropathy.*

LEARN MORE ABOUT NEUREMEDY®

NeuRemedy®

NeuRemedy^®